US Stock MarketDetailed Quotes

CCCC C4 Therapeutics

Watchlist
  • 5.000
  • +0.020+0.40%
Close May 31 16:00 ET
  • 5.010
  • +0.010+0.20%
Post 19:54 ET
344.03MMarket Cap-2109P/E (TTM)

C4 Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
45.30%-18.12M
-0.85%-106.84M
17.57%-24.01M
-9.59%-30.71M
14.41%-19M
-24.55%-33.13M
-21.82%-105.94M
-13.47%-29.13M
-52.63%-28.02M
-23.29%-22.2M
Net income from continuing operations
18.46%-28.36M
-3.37%-132.49M
6.54%-34.75M
15.40%-27.04M
-31.04%-35.92M
-9.99%-34.78M
-52.79%-128.18M
-137.48%-37.19M
-29.47%-31.96M
-21.40%-27.41M
Operating gains losses
----
--621K
--0
----
----
----
----
----
----
----
Depreciation and amortization
-17.80%448K
12.17%1.88M
-17.47%430K
7.71%447K
5.29%458K
78.69%545K
12.33%1.68M
61.30%521K
25.76%415K
12.11%435K
Other non cash items
-13.74%1.49M
0.48%6.64M
-9.58%1.52M
-1.96%1.65M
-7.38%1.75M
26.84%1.73M
209.70%6.61M
173.78%1.68M
228.27%1.68M
273.07%1.88M
Change In working capital
153.97%3.36M
58.65%-6.94M
615.61%3.4M
-220.72%-13.5M
265.40%9.38M
0.37%-6.22M
44.24%-16.78M
96.36%-660K
-262.13%-4.21M
-195.98%-5.67M
-Change in receivables
-290.37%-1.8M
-343.33%-10.33M
-75,433.33%-11.3M
137.84%528K
-893.65%-500K
-76.04%945K
444.48%4.24M
101.72%15K
-83.77%222K
102.46%63K
-Change in prepaid assets
-1,037.75%-4.67M
601.80%2.72M
671.35%1.32M
54.02%-692K
13.09%1.6M
61.17%498K
106.34%388K
103.42%171K
-2,567.21%-1.51M
223.84%1.41M
-Change in payables and accrued expense
-96.45%-7.48M
-9.20%1.59M
231.13%5.35M
-300.00%-1.57M
-62.13%1.62M
22.57%-3.81M
-45.28%1.75M
-44.18%1.62M
-40.75%785K
-7.42%4.27M
-Change in other current liabilities
-11.74%-1.26M
-826.04%-4.7M
-11.46%-1.21M
-176.38%-1.19M
8.70%-1.18M
-469.74%-1.12M
42.91%-507K
-832.76%-1.08M
690.15%1.56M
-400.78%-1.29M
-Change in other working capital
779.71%18.56M
116.65%3.77M
769.49%9.24M
-100.68%-10.57M
177.40%7.84M
53.57%-2.73M
9.57%-22.65M
90.84%-1.38M
-44.25%-5.27M
-294.08%-10.12M
Cash from discontinued investing activities
Operating cash flow
45.30%-18.12M
-0.85%-106.84M
17.57%-24.01M
-9.59%-30.71M
14.41%-19M
-24.55%-33.13M
-21.82%-105.94M
-13.47%-29.13M
-52.63%-28.02M
-23.29%-22.2M
Investing cash flow
Cash flow from continuing investing activities
-199.75%-53.4M
171.04%158.35M
244.09%31.95M
189.87%57.73M
-54.41%15.15M
1,436.94%53.53M
130.86%58.42M
115.63%9.28M
119.79%19.91M
2.45%33.23M
Net PPE purchase and sale
--0
68.92%-1.71M
89.46%-157K
81.85%-600K
31.57%-362K
-242.44%-589K
-330.38%-5.5M
-1,266.97%-1.49M
---3.31M
29.18%-529K
Net investment purchase and sale
-198.66%-53.4M
150.41%160.06M
197.96%32.1M
151.20%58.33M
-54.05%15.51M
1,512.32%54.12M
133.99%63.92M
118.17%10.77M
123.07%23.22M
1.74%33.76M
Cash from discontinued investing activities
Investing cash flow
-199.75%-53.4M
171.04%158.35M
244.09%31.95M
189.87%57.73M
-54.41%15.15M
1,436.94%53.53M
130.86%58.42M
115.63%9.28M
119.79%19.91M
2.45%33.23M
Financing cash flow
Cash flow from continuing financing activities
5,155.99%34.58M
3,865.91%45.49M
122,606.38%57.67M
-3,078.67%-10.75M
-388.03%-746K
-242.50%-684K
-99.33%1.15M
-89.91%47K
-38.18%361K
-99.85%259K
Net issuance payments of debt
--0
---12.5M
--0
---11M
---750K
---750K
--0
--0
--0
--0
Net common stock issuance
36,248.94%33.98M
--57.56M
--57.67M
---16K
--0
---94K
--0
--0
--0
--0
Proceeds from stock option exercised by employees
826.79%519K
-92.54%58K
--0
--0
-99.23%2K
-78.46%56K
-66.65%777K
-93.75%47K
-75.83%211K
-51.95%259K
Net other financing activities
-19.23%84K
-0.54%368K
---1K
75.33%263K
--2K
-52.73%104K
193.67%370K
--0
-16.67%150K
--0
Cash from discontinued financing activities
Financing cash flow
5,155.99%34.58M
3,865.91%45.49M
122,606.38%57.67M
-3,078.67%-10.75M
-388.03%-746K
-242.50%-684K
-99.33%1.15M
-89.91%47K
-38.18%361K
-99.85%259K
Net cash flow
Beginning cash position
293.65%130.03M
-58.40%33.03M
21.95%64.43M
-20.50%48.16M
7.05%52.76M
-58.40%33.03M
-56.92%79.4M
-67.79%52.83M
-78.55%60.58M
-49.45%49.28M
Current changes in cash
-287.26%-36.93M
309.19%97M
431.40%65.61M
310.01%16.27M
-140.69%-4.6M
165.48%19.72M
55.80%-46.37M
76.60%-19.8M
93.46%-7.75M
-93.89%11.29M
End cash Position
76.48%93.1M
293.65%130.03M
293.65%130.03M
21.95%64.43M
-20.50%48.16M
7.05%52.76M
-58.40%33.03M
-58.40%33.03M
-67.79%52.83M
-78.55%60.58M
Free cash flow
46.26%-18.12M
2.59%-108.55M
21.07%-24.17M
0.06%-31.31M
14.81%-19.36M
-25.95%-33.71M
-26.28%-111.44M
-18.77%-30.62M
-70.63%-31.33M
-21.20%-22.72M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 45.30%-18.12M-0.85%-106.84M17.57%-24.01M-9.59%-30.71M14.41%-19M-24.55%-33.13M-21.82%-105.94M-13.47%-29.13M-52.63%-28.02M-23.29%-22.2M
Net income from continuing operations 18.46%-28.36M-3.37%-132.49M6.54%-34.75M15.40%-27.04M-31.04%-35.92M-9.99%-34.78M-52.79%-128.18M-137.48%-37.19M-29.47%-31.96M-21.40%-27.41M
Operating gains losses ------621K--0----------------------------
Depreciation and amortization -17.80%448K12.17%1.88M-17.47%430K7.71%447K5.29%458K78.69%545K12.33%1.68M61.30%521K25.76%415K12.11%435K
Other non cash items -13.74%1.49M0.48%6.64M-9.58%1.52M-1.96%1.65M-7.38%1.75M26.84%1.73M209.70%6.61M173.78%1.68M228.27%1.68M273.07%1.88M
Change In working capital 153.97%3.36M58.65%-6.94M615.61%3.4M-220.72%-13.5M265.40%9.38M0.37%-6.22M44.24%-16.78M96.36%-660K-262.13%-4.21M-195.98%-5.67M
-Change in receivables -290.37%-1.8M-343.33%-10.33M-75,433.33%-11.3M137.84%528K-893.65%-500K-76.04%945K444.48%4.24M101.72%15K-83.77%222K102.46%63K
-Change in prepaid assets -1,037.75%-4.67M601.80%2.72M671.35%1.32M54.02%-692K13.09%1.6M61.17%498K106.34%388K103.42%171K-2,567.21%-1.51M223.84%1.41M
-Change in payables and accrued expense -96.45%-7.48M-9.20%1.59M231.13%5.35M-300.00%-1.57M-62.13%1.62M22.57%-3.81M-45.28%1.75M-44.18%1.62M-40.75%785K-7.42%4.27M
-Change in other current liabilities -11.74%-1.26M-826.04%-4.7M-11.46%-1.21M-176.38%-1.19M8.70%-1.18M-469.74%-1.12M42.91%-507K-832.76%-1.08M690.15%1.56M-400.78%-1.29M
-Change in other working capital 779.71%18.56M116.65%3.77M769.49%9.24M-100.68%-10.57M177.40%7.84M53.57%-2.73M9.57%-22.65M90.84%-1.38M-44.25%-5.27M-294.08%-10.12M
Cash from discontinued investing activities
Operating cash flow 45.30%-18.12M-0.85%-106.84M17.57%-24.01M-9.59%-30.71M14.41%-19M-24.55%-33.13M-21.82%-105.94M-13.47%-29.13M-52.63%-28.02M-23.29%-22.2M
Investing cash flow
Cash flow from continuing investing activities -199.75%-53.4M171.04%158.35M244.09%31.95M189.87%57.73M-54.41%15.15M1,436.94%53.53M130.86%58.42M115.63%9.28M119.79%19.91M2.45%33.23M
Net PPE purchase and sale --068.92%-1.71M89.46%-157K81.85%-600K31.57%-362K-242.44%-589K-330.38%-5.5M-1,266.97%-1.49M---3.31M29.18%-529K
Net investment purchase and sale -198.66%-53.4M150.41%160.06M197.96%32.1M151.20%58.33M-54.05%15.51M1,512.32%54.12M133.99%63.92M118.17%10.77M123.07%23.22M1.74%33.76M
Cash from discontinued investing activities
Investing cash flow -199.75%-53.4M171.04%158.35M244.09%31.95M189.87%57.73M-54.41%15.15M1,436.94%53.53M130.86%58.42M115.63%9.28M119.79%19.91M2.45%33.23M
Financing cash flow
Cash flow from continuing financing activities 5,155.99%34.58M3,865.91%45.49M122,606.38%57.67M-3,078.67%-10.75M-388.03%-746K-242.50%-684K-99.33%1.15M-89.91%47K-38.18%361K-99.85%259K
Net issuance payments of debt --0---12.5M--0---11M---750K---750K--0--0--0--0
Net common stock issuance 36,248.94%33.98M--57.56M--57.67M---16K--0---94K--0--0--0--0
Proceeds from stock option exercised by employees 826.79%519K-92.54%58K--0--0-99.23%2K-78.46%56K-66.65%777K-93.75%47K-75.83%211K-51.95%259K
Net other financing activities -19.23%84K-0.54%368K---1K75.33%263K--2K-52.73%104K193.67%370K--0-16.67%150K--0
Cash from discontinued financing activities
Financing cash flow 5,155.99%34.58M3,865.91%45.49M122,606.38%57.67M-3,078.67%-10.75M-388.03%-746K-242.50%-684K-99.33%1.15M-89.91%47K-38.18%361K-99.85%259K
Net cash flow
Beginning cash position 293.65%130.03M-58.40%33.03M21.95%64.43M-20.50%48.16M7.05%52.76M-58.40%33.03M-56.92%79.4M-67.79%52.83M-78.55%60.58M-49.45%49.28M
Current changes in cash -287.26%-36.93M309.19%97M431.40%65.61M310.01%16.27M-140.69%-4.6M165.48%19.72M55.80%-46.37M76.60%-19.8M93.46%-7.75M-93.89%11.29M
End cash Position 76.48%93.1M293.65%130.03M293.65%130.03M21.95%64.43M-20.50%48.16M7.05%52.76M-58.40%33.03M-58.40%33.03M-67.79%52.83M-78.55%60.58M
Free cash flow 46.26%-18.12M2.59%-108.55M21.07%-24.17M0.06%-31.31M14.81%-19.36M-25.95%-33.71M-26.28%-111.44M-18.77%-30.62M-70.63%-31.33M-21.20%-22.72M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg